Rain Therapeutics Inc. (RAIN) Social Stream
Rain Therapeutics Inc (RAIN) Price Targets From Analysts
Use the tables below to see what analysts covering Rain Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 39 weeks, RAIN's average price target has gone down $8.66.
Over the past 39 weeks, RAIN's average upside potential has been 112.66%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RAIN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
RAIN's average broker recommendation rating improved by 0.5 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Rain Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 284.83% of that group.
- In terms of how Rain Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than 69.67% of that group.
- Rain Therapeutics Inc's number of analysts covering the stock is greater than 41.36% of all US stocks.
- Rain Therapeutics Inc's average analyst price target is greater than 183.17% of stocks in the small market cap category.
In the Pharmaceutical Products industry, PYXS, PVCT, and PRVB are the three stocks most similar to Rain Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is RAIN a Buy, Hold or Sell? See the POWR Ratings now!